中晚期宫颈癌图像引导放射治疗的剂量学研究
Dosimetric Study of Image-Guided Radiotherapy for Advanced Cervical Cancer
DOI: 10.12677/acm.2025.1572130, PDF,    科研立项经费支持
作者: 方 婧*, 张明霞, 蒋 俊, 陈香存, 钱雅琴, 汪 浩#:安徽医科大学第一附属医院肿瘤放疗科,安徽 合肥
关键词: 宫颈癌图像引导放射治疗剂量学Cervical Cancer Image-Guided Radiotherapy Dosimetry
摘要: 目的:探讨中晚期宫颈癌5野、7野、9野3种图像引导放射治疗计划的靶区和危及器官的剂量学差异。方法:选取本院47例局部晚期宫颈癌患者,经定位、CT扫描及靶区勾画后,分别设计5野、7野、9野IGRT计划。分析靶区的剂量学参数、均匀性和适形性指数,以及危及器官的剂量学参数。结果:5野计划中PTV的HI和CI明显劣于7野和9野,5野计划中直肠的V30V40,膀胱的V20V40,左侧股骨头的V40V50和右侧股骨头的V30V40V50明显高于7野和9野计划,差异均有统计学意义。而7野和9野计划间靶区和危及器官剂量参数相近,差异无明显统计学意义。结论:在权衡靶区和危及器官的剂量学参数要求方面,7野图像引导放射治疗计划可以作为中晚期宫颈癌临床首选的治疗计划。
Abstract: Objective: To compare the dosimetric differences of target areas and organs at risk among three image-guided radiotherapy plans for advanced cervical cancer. Methods: Forty-seven patients with advanced cervical cancer in our hospital were selected. 5-field, 7-field and 9-field IGRT plans were designed after localization, CT scan and target area delineation. The dose parameters, uniformity and conformity index of target area, and dosimetric parameters of organs at risk were analyzed. Results: The HI and CI of PTV in 5-field plan were significantly inferior to those in 7-field and 9-field plans. Moreover, the V30, V40 of rectum, V20 and V40 of bladder, V40, V50 of left femoral head and V30, V40 and V50 of right femoral head in 5-field plan were significantly higher than those in 7-field plan and 9-field plan, and the difference was statistically significant. There was no significant difference in target and organ at risk dose parameters between the 7-field and 9-field plans. Conclusion: In terms of weighing the dosimetric parameters of target area and organs at risk, 7-field image-guided radiotherapy plan can be the first choice for the treatment of advanced cervical cancer.
文章引用:方婧, 张明霞, 蒋俊, 陈香存, 钱雅琴, 汪浩. 中晚期宫颈癌图像引导放射治疗的剂量学研究[J]. 临床医学进展, 2025, 15(7): 1318-1324. https://doi.org/10.12677/acm.2025.1572130

参考文献

[1] Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. [Google Scholar] [CrossRef] [PubMed]
[2] Han, B., Zheng, R., Zeng, H., Wang, S., Sun, K., Chen, R., et al. (2024) Cancer Incidence and Mortality in China, 2022. Journal of the National Cancer Center, 4, 47-53. [Google Scholar] [CrossRef] [PubMed]
[3] Cohen, C.M., Wentzensen, N., Castle, P.E., Schiffman, M., Zuna, R., Arend, R.C., et al. (2023) Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype. Journal of Clinical Oncology, 41, 1059-1068. [Google Scholar] [CrossRef] [PubMed]
[4] Francoeur, A.A., Monk, B.J. and Tewari, K.S. (2025) Treatment Advances across the Cervical Cancer Spectrum. Nature Reviews Clinical Oncology, 22, 182-199. [Google Scholar] [CrossRef] [PubMed]
[5] 鄂明艳, 董丽华. 肿瘤放射治疗学[M]. 第4版. 北京: 人民卫生出版社, 2022: 384.
[6] de Crevoisier, R., Lafond, C., Mervoyer, A., Hulot, C., Jaksic, N., Bessières, I., et al. (2022) Image-guided Radiotherapy. Cancer/Radiothérapie, 26, 34-49. [Google Scholar] [CrossRef] [PubMed]
[7] Kraynak, J. and Marciscano, A.E. (2023) Image-Guided Radiation Therapy of Tumors in Preclinical Models. In: Mazeron, P.J.-J., Ed., Methods in Cell Biology, Elsevier, 1-13. [Google Scholar] [CrossRef] [PubMed]
[8] 马娜, 曲宝林, 解传滨, 等. 肿瘤精确放射治疗技术的发展与挑战[J]. 中国医疗设备, 2021, 36(12): 149-153.
[9] 文多成, 郑安梅, 苟秋燕, 等. 图像引导放射治疗技术中宫颈癌调强放射治疗的摆位误差研究[J]. 甘肃医药, 2023, 42(4): 335-337.
[10] 张倩, 杜雷亚, 张霞, 等. 宫颈癌调强放疗中提高摆位误差精度的研究进展[J]. 肿瘤预防与治疗, 2022, 35(1): 87-91.
[11] Tegtmeier, R.C., Ferris, W.S., Bayouth, J.E., Miller, J.R. and Culberson, W.S. (2022) Characterization of Imaging Performance of a Novel Helical KVCT for Use in Image‐Guided and Adaptive Radiotherapy. Journal of Applied Clinical Medical Physics, 23, e13648. [Google Scholar] [CrossRef] [PubMed]
[12] Guberina, M., Santiago Garcia, A., Khouya, A., Pöttgen, C., Holubyev, K., Ringbaek, T.P., et al. (2023) Comparison of Online-Onboard Adaptive Intensity-Modulated Radiation Therapy or Volumetric-Modulated Arc Radiotherapy with Image-Guided Radiotherapy for Patients with Gynecologic Tumors in Dependence on Fractionation and the Planning Target Volume Margin. JAMA Network Open, 6, e234066. [Google Scholar] [CrossRef] [PubMed]
[13] Pötter, R., Tanderup, K., Schmid, M.P., Jürgenliemk-Schulz, I., Haie-Meder, C., Fokdal, L.U., et al. (2021) MRI-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer (EMBRACE-I): A Multicentre Prospective Cohort Study. The Lancet Oncology, 22, 538-547. [Google Scholar] [CrossRef] [PubMed]
[14] Patil, G., Br, K.K. and Narayanan, G. (2022) Inter-Fractional Variations in Volume and Radiation Dose to the Organs at Risk, High-Risk Clinical Target Volume and Implication of Image-Guided Adaptive Planning during Intracavitary Brachytherapy of Carcinoma Cervix. Cureus, 14, e21503. [Google Scholar] [CrossRef] [PubMed]
[15] 周春, 成俊, 姜玉玲. 电子影像系统测量宫颈癌真空体膜固定摆位误差分析及质量控制[J]. 中国医疗器械信息, 2022, 28(3): 92-94.
[16] Chandra, R.A., Keane, F.K., Voncken, F.E.M. and Thomas, C.R. (2021) Contemporary Radiotherapy: Present and Future. The Lancet, 398, 171-184. [Google Scholar] [CrossRef] [PubMed]